Other mechanisms include the rearrangement of the tumor architecture (e.g., via MMPs [122]), the induction of tumor cell proliferation and survival (e.g., through epidermal growth factor [123] or IL-6 [124]), and the suppression of anti-cancer immunity (e.g., via PD-L1 [125]). Here, CD274 is linked to neoplasm.